Impact of mesenchymal stem cell senescence on inflammaging = Impact of mesenchymal stem cell senescence on inflammaging

다국어 초록 (Multilingual Abstract)

Life expectancy has dramatically increased around the world over the last few decades, and staying healthier longer, without chronic disease, has become an important issue. Although understanding aging is a grand challenge, our understanding of the mechanisms underlying the degeneration of cell and tissue functions with age and its contribution to chronic disease has greatly advanced during the past decade. As our immune system alters with aging, abnormal activation of immune cells leads to imbalance of innate and adaptive immunity and develops a persistent and mild systemic inflammation, inflammaging. With their unique therapeutic properties, such as immunomodulation and tissue regeneration, mesenchymal stem cells (MSCs) have been considered to be a promising source for treating autoimmune disease or as anti-aging therapy. Although direct evidence of the role of MSCs in inflammaging has not been thoroughly studied, features reported in senescent MSCs or the aging process of MSCs are associated with inflammaging; MSC niche-driven skewing of hematopoiesis toward the myeloid lineage or oncogenesis, production of pro-inflammatory cytokines, and weakening their modulative property on macrophage polarization, which plays a central role on inflammaging development. This review explores the role of senescent MSCs as an important regulator for onset and progression of inflammaging and as an effective target for anti-aging strategies. [BMB Reports 2020; 53(2): 65-73]

참고문헌 (Reference)

1 Coppe JP, "The senescence-associated secretory phenotype : the dark side of tumor suppression" 5 : 99-118, 2010

2 Calcada D, "The role of low-grade inflammation and metabolic flexibility in aging and nutritional modulation thereof : a systems biology approach" 136-137 : 138-147, 2014

3 Ghajar CM, "The perivascular niche regulates breast tumour dormancy" 15 : 807-817, 2013

4 Suijker J, "The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or-2 blocks osteoblast differentiation in vitro and in vivo" 6 : 14832-14842, 2015

5 Yu KR, "The impact of aging on primate hematopoiesis as interrogated by clonal tracking" 131 : 1195-1205, 2018

6 Lehmann BD, "Senescence-associated exosome release from human prostate cancer cells" 68 : 7864-7871, 2008

7 Li Y, "Senescence of mesenchymal stem cells(Review)" 39 : 775-782, 2017

8 Turinetto V, "Senescence in Human Mesenchymal Stem Cells : Functional Changes and Implications in Stem Cell-Based Therapy" 17 : 1164-, 2016

9 Inoue S, "Roles of IDH1/2 and TET2 mutations in myeloid disorders" 103 : 627-633, 2016

10 Smolen JS, "Rheumatoid arthritis" 388 : 2023-2038, 2016

11 Wagner W, "Replicative senescence of mesenchymal stem cells : a continuous and organized process" 3 : e2213-, 2008

12 Busque L, "Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis" 44 : 1179-1181, 2012

13 Ergen AV, "Rantes/Ccl5influences hematopoietic stem cell subtypes and causes myeloid skewing" 119 : 2500-2509, 2012

14 Balandran JC, "Proinflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic Progression at the Expense of Normal Lymphopoiesis" 7 : 666-, 2016

15 Carvalho JL, "Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction" 17 : 617-625, 2013

16 Badiavas AR, "Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing" 11 : 1447-1454, 2011

17 Latz E, "NLRP3 inflammasome activation in inflammaging" 40 : 61-73, 2018

18 Uni M, "Modeling ASXL1mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification" 33 : 191-204, 2019

19 Salminen A, "Mitochondrial dysfunction and oxidative stress activate inflammasomes : impact on the aging process and age-related diseases" 69 : 2999-3013, 2012

20 Mokarizadeh A, "Microvesicles derived from mesenchymal stem cells : potent organelles for induction of tolerogenic signaling" 147 : 47-54, 2012

21 Lei Q, "Microvesicles as Potential Biomarkers for the Identification of Senescence in Human Mesenchymal Stem Cells" 7 : 2673-2689, 2017

22 Burger D, "Microparticles induce cell cycle arrest through redoxsensitive processes in endothelial cells : implications in vascular senescence" 1 : e001842-, 2012

23 Pajarinen J, "Mesenchymal stem cell-macrophage crosstalk and bone healing" 196 : 80-89, 2019

24 Yeo RW, "Mesenchymal stem cell : an efficient mass producer of exosomes for drug delivery" 65 : 336-341, 2013

25 Zambetti NA, "Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia" 19 : 613-627, 2016

26 Martucci M, "Mediterranean diet and inflammaging within the hormesis paradigm" 75 : 442-455, 2017

27 Oishi Y, "Macrophages in age-related chronic inflammatory diseases" 2 : 16018-, 2016

28 Zhang P, "Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates" 4 : 4-, 2018

29 강주빈, "Lipopolysaccharide induces neuroglia activation and NF-κB activation in cerebral cortex of adult mice" 한국실험동물학회 35 (35): 132-139, 2019

30 Agarwal S, "Innate and adaptive immunosenescence" 104 : 183-190, 2010

31 Yin Y, "Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture" 8 : 153-, 2017

32 Lepperdinger G, "Inflammation and mesenchymal stem cell aging" 23 : 518-524, 2011

33 Libby P, "Inflammation and atherosclerosis" 105 : 1135-1143, 2002

34 Franceschi C, "Inflammaging. An evolutionary perspective on immunosenescence" 908 : 244-254, 2000

35 Frasca D, "Inflammaging decreases adaptive and innate immune responses in mice and humans" 17 : 7-19, 2016

36 Minciullo PL, "Inflammaging and Anti-Inflammaging : The Role of Cytokines in Extreme Longevity" 64 : 111-126, 2016

37 Franceschi C, "Inflammaging and 'Garb-aging'" 28 : 199-212, 2017

38 Salminen A, "Inflammaging : disturbed interplay between autophagy and inflammasomes" 4 : 166-175, 2012

39 Franceschi C, "Inflammaging : a new immune-metabolic viewpoint for age-related diseases" 14 : 576-, 2018

40 Bonafe M, "Inflamm-aging of the stem cell niche : breast cancer as a paradigmatic example : breakdown of the multi-shell cytokine network fuels cancer in aged people" 34 : 40-49, 2012

41 Chazaud B, "Inflamm-aging : STAT3 signaling pushes muscle stem cells off balance" 15 : 401-402, 2014

42 Kovtonyuk LV, "Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment" 7 : 502-, 2016

43 O'Hagan-Wong K, "Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis" 7 : 13285-13296, 2016

44 Balasubramanyam M, "Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes" 351 : 197-205, 2011

45 Fulop T, "Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?" 8 : 1960-, 2017

46 de Witte SFH, "Immunomodulation By Therapeutic Mesenchymal Stromal Cells(MSC)Is Triggered Through Phagocytosis of MSC By Monocytic Cells" 36 : 602-615, 2018

47 Franceschi C, "Immunobiography and the Heterogeneity of Immune Responses in the Elderly : A Focus on Inflammaging and Trained Immunity" 8 : 982-, 2017

48 Heppner FL, "Immune attack : the role of inflammation in Alzheimer disease" 16 : 358-372, 2015

49 Di GH, "IL-6secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells" 9 : e113572-, 2014

50 Valli A, "Hypoxia metabolism in ageing" 7 : 465-466, 2015

51 Xing J, "Hypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota" 9 : 2020-, 2018

52 Intlekofer AM, "Hypoxia Induces Production of L-2-Hydroxyglutarate" 22 : 304-311, 2015

53 Sun X, "Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats" 8 : 241-, 2017

54 Shin TH, "Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis" 7 : e2524-, 2016

55 Pang WW, "Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age" 108 : 20012-20017, 2011

56 Pisetsky DS, "High-mobility group box protein 1(HMGB1) : an alarmin mediating the pathogenesis of rheumatic disease" 10 : 209-, 2008

57 Geiger H, "Hematopoietic stem cell aging" 29 : 86-92, 2014

58 Derhovanessian E, "Hallmark features of immunosenescence are absent in familial longevity" 185 : 4618-4624, 2010

59 Kontis V, "Future life expectancy in 35 industrialised countries : projections with a Bayesian model ensemble" 389 : 1323-1335, 2017

60 Szarc vel Szic K, "From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?" 7 : 33-, 2015

61 Robbins PD, "Extracellular vesicles and aging" 4 : 98-, 2017

62 Fleshner M, "Exosomes, DAMPs and miRNA : Features of Stress Physiology and Immune Homeostasis" 38 : 768-776, 2017

63 Katakowski M, "Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth" 335 : 201-204, 2013

64 Lai RC, "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury" 4 : 214-222, 2010

65 Shepherd MS, "Emerging single-cell tools are primed to reveal functional and molecular heterogeneity in malignant hematopoietic stem cells" 26 : 214-221, 2019

66 Cicione C, "Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential" 2013 : 232896-, 2013

67 Lloberas J, "Effect of aging on macrophage function" 37 : 1325-1331, 2002

68 Yang YM, "Effect of aged bone marrow microenvironment on mesenchymal stem cell migration" 37 : 16-, 2015

69 강인선, "Donor-dependent variation of human umbilical cord blood mesenchymal stem cells in response to hypoxic preconditioning and amelioration of limb ischemia" 생화학분자생물학회 50 : 1-15, 2018

70 Lee BC, "Disease-specific primed human adult stem cells effectively ameliorate experimental atopic dermatitis in mice" 9 : 3608-3621, 2019

71 Romieu-Mourez R, "Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype" 182 : 7963-7973, 2009

72 Steele AK, "Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signature" 9 : e97171-, 2014

73 Wilson NK, "Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations" 16 : 712-724, 2015

74 Chen Z, "Cohesin-mediated NF-kappaB signaling limits hematopoietic stem cell self-renewal in aging and inflammation" 216 : 152-175, 2019

75 Franceschi C, "Chronic inflammation(inflammaging)and its potential contribution to ageassociated diseases" 69 (69): S4-S9, 2014

76 Baker N, "Characterization of bone marrow-derived mesenchymal stem cells in aging" 70 : 37-47, 2015

77 Castilho JL, "CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy" 30 : 899-908, 2016

78 Gibson KL, "B-cell diversity decreases in old age and is correlated with poor health status" 8 : 18-25, 2009

79 Lim Z, "Allogeneic hematopoietic stem-cell transplantation for patients 50years or older with myelodysplastic syndromes or secondary acute myeloid leukemia" 28 : 405-411, 2010

80 Yu KR, "Aging-related genes in mesenchymal stem cells : a mini-review" 59 : 557-563, 2013

81 Mattiucci D, "Aging-and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes" 27 : 754-764, 2018

82 Bonab MM, "Aging of mesenchymal stem cell in vitro" 7 : 14-, 2006

83 de Haan G, "Aging of hematopoietic stem cells" 131 : 479-487, 2018

84 Cartwright MJ, "Aging in adipocytes : potential impact of inherent, depot-specific mechanisms" 42 : 463-471, 2007

85 Linehan E, "Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis" 13 : 699-708, 2014

86 Fransen F, "Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice" 8 : 1385-, 2017

87 Peffers MJ, "Age-related changes in mesenchymal stem cells identified using a multi-omics approach" 31 : 136-159, 2016

88 Kim M, "Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential : implication to age-associated bone diseases and defects" 133 : 215-225, 2012

89 Starr ME, "Age-associated increase in cytokine production during systemic inflammation : adipose tissue as a major source of IL-6" 64 : 723-730, 2009

90 Pang WW, "Age-associated changes in human hematopoietic stem cells" 54 : 39-42, 2017

91 Ramasamy R, "Advanced glycation end products and RAGE : a common thread in aging, diabetes, neurodegeneration, and inflammation" 15 : 16R-28R, 2005

92 Bilwani FA, "Adipocyte-derived soluble factor(s)inhibits early stages of B lymphopoiesis" 189 : 4379-4386, 2012

93 Justesen J, "Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis" 2 : 165-171, 2001

94 Ambrosi TH, "Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration" 20 : 771-784 e776, 2017

95 Salminen A, "Activation of innate immunity system during aging : NF-kB signaling is the molecular culprit of inflamm-aging" 7 : 83-105, 2008

96 Abdel-Wahab O, "ASXL1mutations promote myeloid transformation through loss of PRC2-mediated gene repression" 22 : 180-193, 2012

97 Rohatgi N, "ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1" 2 : 2467-2477, 2018

98 Yu KR, "A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging" 9 : e102426-, 2014